IBRX

NASDAQ · Biotechnology

Immunitybio Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.07

+0.66 (+8.83%)

As of Mar 25, 9:50 PM ET ·

Day Range $7.45 — $8.35

52W Range $1.83 — $8.95

Performance

1D —

1W —

1M —

3M +277.10%

6M +214.01%

1Y +190.29%

YTD +299.50%

Open$7.75

Previous Close$7.42

Day High$8.35

Day Low$7.45

52W High$8.95

52W Low$1.83

Volume—

Avg Volume30.31M

Market Cap8.48B

P/E Ratio—

EPS$-0.41

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $4.22 Above

SMA 200 $2.95 Above

RSI (14) 70.9 Overbought

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

11 analysts

10 Buy 1 Hold 0 Sell

Price Target +1,248.1% upside

Current
$8.07

Target
$108.79

$71.54 $108.79 avg $142.95

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	20.88M	1.55B	1.61B
Net Income	-586,909,544	174.18M	206.87M
Profit Margin	-2,804.8%	11.2%	12.9%
EBITDA	-448,469,744	310.76M	319.11M
Free Cash Flow	—	125.72M	219.44M
Rev Growth	+151.2%	+14.4%	+15.1%
Debt/Equity	0.01	0.68	0.80

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$207.18	+0.96%	166.6	397.77B
AMGN	Amgen Inc	$353.93	+1.58%	24.4	188.06B
GILD	Gilead Sciences Inc	$138.26	+0.11%	20.0	170.34B
VRTX	Vertex Pharmaceuticals Inc	$454.97	+1.42%	29.2	115.53B
REGN	Regeneron Pharmaceuticals	$749.47	+1.05%	17.9	80.50B
ALNY	Alnylam Pharmaceuticals Inc	$328.70	+6.70%	139.7	43.84B